Odyssey Therapeutics Reports Q2 2026 Financial Results

What Happened

• On August 4, 2026, Odyssey Therapeutics, Inc. announced its financial results for the three months ended June 30, 2026 via a press release furnished as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02). The 8-K states the press release is furnished, not “filed,” under the Exchange Act.

Key Details

• Announcement date: August 4, 2026.
• Reporting period: three months ended June 30, 2026.
• Press release included as Exhibit 99.1 to the Form 8-K.
• Form 8-K signed by Jason Haas, Chief Financial Officer.

Why It Matters

• This filing signals Odyssey has released its latest quarterly earnings information; investors should review the Exhibit 99.1 press release for revenue, expenses, cash position, and forward guidance (if provided).
• The 8-K’s “furnished, not filed” status is a legal designation that limits certain liabilities but does not change the substance of the disclosed results.
• If you hold or watch ODTX stock, read the press release to see the company’s reported earnings metrics and any management commentary that could affect near-term valuation or expectations.